Built around Cellebrite’s industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missions
ATLANTA, Aug. 25, 2026 /PRNewswire/ — Airway Therapeutics, Inc., a late-stage clinical biopharmaceutical company developing novel biologic therapies for respiratory, inflammatory, and infectious diseases, today announced the closing of a $50 million equity round to support the continued late-stage clinical
BEIJING, Aug. 21, 2026 /PRNewswire/ — A delegation of 55 young media representatives from seven African countries, including Cote d’Ivoire, Comoros, the Central African Republic, Mauritania, Mauritius, Cameroon, and Burkina Faso, recently visited central China’s Hunan Province. They gained first-hand insights
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 19, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that Cellebrite Genesis is expanding
BENGALURU, India, Aug. 18, 2026 /PRNewswire/ — Prodigy Technovations Pvt. Ltd, a leader in protocol analysis solutions, proudly announces the successful testing and launch of the PGY-UFS5-EX-PA. This groundbreaking tool is the industry’s first UFS 5.0 protocol exerciser and analyzer designed to
CHATSWORTH, Calif., Aug. 18, 2026 /PRNewswire/ — Aitech, a global leader in AI-powered rugged embedded computing and connectivity systems for defense and space applications, today announced the new U-C6850 10/40GbE Fully Managed Ethernet Switch/Router, a SOSA®-aligned, high-speed, flexible and secure Ethernet
First study patient treated by Dr. Reem Sharaiha at NewYork-Presbyterian/Weill Cornell Medical Center.
U.S. Department of Veterans Affairs sites begin prescribing Proliv®Rx for major depressive disorder and Relivion®MG for migraine, expanding veterans’ access to non-invasive, physician-supervised neuromodulation therapy at home
Partnership delivers consistent, high-performance AI storage across Andromeda’s global provider network, lowering the total cost of innovation for AI teams
Business development and corporate strategy executive joins Board as Company advances its clinical programs and partnering activity
Milestone reflects continued execution of the Company’s pivotal U.S. clinical study evaluating EndoZip™ for Endoscopic Sleeve Gastroplasty
The most significant software release in the company’s history extends what’s possible for agentic AI and other accelerated compute workloads. NeuralMesh 6 redefines inference economics with native multi-tenancy, a unified file-and-object protocol stack built on NVMe, intelligent data mobility with replication
New WEKA-engineered systems dramatically reduce energy consumption, infrastructure costs, operational complexity, and shrink the datacenter footprint, achieving 267% higher effective capacity density and 114% higher performance density than market alternatives in a single rack for highly efficient, production-ready AI factories
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its second-quarter
In an AI-first category, Playroll won two golds for a contrarian bet: use AI to back people, not replace them, on infrastructure it owns.
The commercial agreement combines proven FocalPoint S-GNSS® Auto software with STMicroelectronics Teseo hardware to improve positioning reliability in challenging GNSS environments
The partnership unifies what happens in the sky with what’s stored on the drone in a single investigative workflow
– Jiahui International Cancer Center (JICC) has welcomed the world’s first international patient to begin treatment with Satri-cel, the world’s first approved CAR-T therapy for a solid tumor, marking a historic milestone in expanding global access to China’s latest oncology
– Roland Berger, the only leading global consultancy of European origin, generated revenues of €1.01 billion in 2025, making it the strongest financial year in the firm’s history.
Reduces investigative workloads from weeks to minutes accelerating investigations like never before